Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)
China
· Delayed Price · Currency is CNY 9.99
+0.02 (0.20%)
May 27, 2025, 2:45 PM CST
SHA:603520 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -47.04 | -49.1 | 44.23 | -75.85 | 323.75 | 238.73 | Upgrade
|
| Depreciation & Amortization | 220.73 | 220.73 | 179.55 | 160.44 | 154.97 | 126.23 | Upgrade
|
| Other Amortization | 7.16 | 7.16 | 6.5 | 8.53 | 4.16 | 2.86 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | -0.01 | -3.53 | 3.39 | 4.34 | 2.45 | Upgrade
|
| Asset Writedown & Restructuring Costs | 13.72 | 13.72 | 4.34 | 114.75 | -0.32 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 6.69 | 6.69 | 10.3 | -11.67 | -7.39 | -3.81 | Upgrade
|
| Provision & Write-off of Bad Debts | -1.87 | -1.87 | -10.61 | 0.14 | 13.1 | 3.41 | Upgrade
|
| Other Operating Activities | 114.31 | 134.17 | 125.66 | 133.98 | 80.8 | 87.88 | Upgrade
|
| Change in Accounts Receivable | -359.66 | -359.66 | 160.47 | -187.88 | -349.61 | -131.98 | Upgrade
|
| Change in Inventory | -2.19 | -2.19 | -465.85 | -281.59 | -9.52 | -202.64 | Upgrade
|
| Change in Accounts Payable | 238.67 | 238.67 | -5.96 | 58.93 | 292.64 | 52.03 | Upgrade
|
| Change in Other Net Operating Assets | 0.42 | 0.42 | 0.04 | 5.19 | 10.83 | - | Upgrade
|
| Operating Cash Flow | 175.7 | 193.5 | 44.55 | -78.37 | 508.84 | 174.48 | Upgrade
|
| Operating Cash Flow Growth | -1.69% | 334.33% | - | - | 191.63% | -29.29% | Upgrade
|
| Capital Expenditures | -461.94 | -480.62 | -266.22 | -472.18 | -303.88 | -153.17 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.27 | 1.27 | 18.88 | 1.68 | 7.25 | 14.02 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -21.71 | - | Upgrade
|
| Divestitures | - | - | - | 30.93 | - | - | Upgrade
|
| Investment in Securities | -11.3 | -11.3 | -8.22 | 110.25 | 36.06 | -172.61 | Upgrade
|
| Other Investing Activities | -0.09 | -0.09 | 1.57 | -2.9 | - | - | Upgrade
|
| Investing Cash Flow | -472.06 | -490.74 | -253.99 | -332.22 | -282.28 | -311.76 | Upgrade
|
| Long-Term Debt Issued | - | 2,064 | 2,851 | 2,069 | 1,208 | 1,713 | Upgrade
|
| Long-Term Debt Repaid | - | -2,571 | -2,562 | -1,228 | -1,393 | -1,689 | Upgrade
|
| Net Debt Issued (Repaid) | -453.49 | -506.72 | 288.84 | 840.13 | -184.68 | 24.28 | Upgrade
|
| Issuance of Common Stock | 934.98 | 934.98 | - | - | 3.4 | 698.07 | Upgrade
|
| Repurchase of Common Stock | - | - | -10.18 | -2.85 | -1.41 | - | Upgrade
|
| Common Dividends Paid | -125.98 | -128.42 | -195.65 | -217.6 | -201 | -149 | Upgrade
|
| Other Financing Activities | -185.1 | -0.81 | - | -256.1 | 81.9 | -35.59 | Upgrade
|
| Financing Cash Flow | 170.41 | 299.03 | 83.01 | 363.58 | -301.79 | 537.75 | Upgrade
|
| Foreign Exchange Rate Adjustments | -19.38 | -20.7 | 0.82 | 11.51 | 0.24 | -5.49 | Upgrade
|
| Net Cash Flow | -145.32 | -18.91 | -125.61 | -35.5 | -74.99 | 394.98 | Upgrade
|
| Free Cash Flow | -286.24 | -287.12 | -221.67 | -550.56 | 204.96 | 21.31 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 861.68% | -81.22% | Upgrade
|
| Free Cash Flow Margin | -11.96% | -12.22% | -10.09% | -25.83% | 10.25% | 1.56% | Upgrade
|
| Free Cash Flow Per Share | -0.63 | -0.70 | -0.65 | -1.60 | 0.59 | 0.06 | Upgrade
|
| Cash Income Tax Paid | - | -7.45 | -51.86 | 43.99 | 86.16 | 53.39 | Upgrade
|
| Levered Free Cash Flow | -191.85 | -119.31 | -283.69 | -639.09 | -100.76 | 274.81 | Upgrade
|
| Unlevered Free Cash Flow | -133.59 | -59.21 | -219.56 | -581.22 | -54.62 | 332.34 | Upgrade
|
| Change in Net Working Capital | -70.87 | -154.29 | 234.12 | 364.97 | 185.57 | -136.79 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.